Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Spatiotemporally restricted arenavirus replication induces immune surveillance and type I interferon-dependent tumour regression.

Kalkavan H, Sharma P, Kasper S, Helfrich I, Pandyra AA, Gassa A, Virchow I, Flatz L, Brandenburg T, Namineni S, Heikenwalder M, Höchst B, Knolle PA, Wollmann G, von Laer D, Drexler I, Rathbun J, Cannon PM, Scheu S, Bauer J, Chauhan J, Häussinger D, Willimsky G, Löhning M, Schadendorf D, Brandau S, Schuler M, Lang PA, Lang KS.

Nat Commun. 2017 Mar 1;8:14447. doi: 10.1038/ncomms14447.

2.

Lymphocytic Choriomeningitis Virus Differentially Affects the Virus-Induced Type I Interferon Response and Mitochondrial Apoptosis Mediated by RIG-I/MAVS.

Pythoud C, Rothenberger S, Martínez-Sobrido L, de la Torre JC, Kunz S.

J Virol. 2015 Jun;89(12):6240-50. doi: 10.1128/JVI.00610-15. Epub 2015 Apr 1.

3.

Role of interferon regulatory factor 7 in T cell responses during acute lymphocytic choriomeningitis virus infection.

Zhou S, Cerny AM, Fitzgerald KA, Kurt-Jones EA, Finberg RW.

J Virol. 2012 Oct;86(20):11254-65. Epub 2012 Aug 8.

4.

CD40 ligand is pivotal to efficient control of virus replication in mice infected with lymphocytic choriomeningitis virus.

Thomsen AR, Nansen A, Christensen JP, Andreasen SO, Marker O.

J Immunol. 1998 Nov 1;161(9):4583-90.

5.

IRF7-dependent type I interferon production induces lethal immune-mediated disease in STAT1 knockout mice infected with lymphocytic choriomeningitis virus.

Li W, Hofer MJ, Jung SR, Lim SL, Campbell IL.

J Virol. 2014 Jul;88(13):7578-88. doi: 10.1128/JVI.03117-13. Epub 2014 Apr 23.

6.

Identification and Mechanism of Action of a Novel Small-Molecule Inhibitor of Arenavirus Multiplication.

Ngo N, Henthorn KS, Cisneros MI, Cubitt B, Iwasaki M, de la Torre JC, Lama J.

J Virol. 2015 Nov;89(21):10924-33. doi: 10.1128/JVI.01587-15. Epub 2015 Aug 19. Erratum in: J Virol. 2016 Aug 26;90(18):8381.

7.

Role of PKR and Type I IFNs in viral control during primary and secondary infection.

Nakayama Y, Plisch EH, Sullivan J, Thomas C, Czuprynski CJ, Williams BR, Suresh M.

PLoS Pathog. 2010 Jun 24;6(6):e1000966. doi: 10.1371/journal.ppat.1000966.

8.

Role of type I interferon signaling in human metapneumovirus pathogenesis and control of viral replication.

Hastings AK, Erickson JJ, Schuster JE, Boyd KL, Tollefson SJ, Johnson M, Gilchuk P, Joyce S, Williams JV.

J Virol. 2015 Apr;89(8):4405-20. doi: 10.1128/JVI.03275-14. Epub 2015 Feb 4.

9.

Virus-induced transient immune suppression and the inhibition of T cell proliferation by type I interferon.

Marshall HD, Urban SL, Welsh RM.

J Virol. 2011 Jun;85(12):5929-39. doi: 10.1128/JVI.02516-10. Epub 2011 Apr 6.

10.

Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines.

Cheng BY, Ortiz-Riaño E, de la Torre JC, Martínez-Sobrido L.

J Virol. 2015 Jul;89(14):7373-84. doi: 10.1128/JVI.00307-15. Epub 2015 May 13.

11.

Combined PD-1 blockade and GITR triggering induce a potent antitumor immunity in murine cancer models and synergizes with chemotherapeutic drugs.

Lu L, Xu X, Zhang B, Zhang R, Ji H, Wang X.

J Transl Med. 2014 Feb 7;12:36. doi: 10.1186/1479-5876-12-36.

12.

A multivalent vaccination strategy for the prevention of Old World arenavirus infection in humans.

Botten J, Whitton JL, Barrowman P, Sidney J, Whitmire JK, Alexander J, Kotturi MF, Sette A, Buchmeier MJ.

J Virol. 2010 Oct;84(19):9947-56. doi: 10.1128/JVI.00672-10. Epub 2010 Jul 28.

13.

Two separate mechanisms of enforced viral replication balance innate and adaptive immune activation.

Shaabani N, Khairnar V, Duhan V, Zhou F, Tur RF, Häussinger D, Recher M, Tumanov AV, Hardt C, Pinschewer D, Christen U, Lang PA, Honke N, Lang KS.

J Autoimmun. 2016 Feb;67:82-89. doi: 10.1016/j.jaut.2015.10.004. Epub 2015 Nov 7.

PMID:
26553386
14.

Negative regulation of type I IFN expression by OASL1 permits chronic viral infection and CD8⁺ T-cell exhaustion.

Lee MS, Park CH, Jeong YH, Kim YJ, Ha SJ.

PLoS Pathog. 2013;9(7):e1003478. doi: 10.1371/journal.ppat.1003478. Epub 2013 Jul 18.

15.

The Z proteins of pathogenic but not nonpathogenic arenaviruses inhibit RIG-I-like receptor-dependent interferon production.

Xing J, Ly H, Liang Y.

J Virol. 2015 Mar;89(5):2944-55. doi: 10.1128/JVI.03349-14. Epub 2014 Dec 31. Erratum in: J Virol. 2015 Jun;89(11):6161.

16.

Dampened antiviral immunity to intravaginal exposure to RNA viral pathogens allows enhanced viral replication.

Khan S, Woodruff EM, Trapecar M, Fontaine KA, Ezaki A, Borbet TC, Ott M, Sanjabi S.

J Exp Med. 2016 Dec 12;213(13):2913-2929. Epub 2016 Nov 16.

17.

Polymicrobial Sepsis Increases Susceptibility to Chronic Viral Infection and Exacerbates CD8+ T Cell Exhaustion.

Condotta SA, Khan SH, Rai D, Griffith TS, Badovinac VP.

J Immunol. 2015 Jul 1;195(1):116-25. doi: 10.4049/jimmunol.1402473. Epub 2015 May 15.

18.

Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection.

Penaloza-MacMaster P, Kamphorst AO, Wieland A, Araki K, Iyer SS, West EE, O'Mara L, Yang S, Konieczny BT, Sharpe AH, Freeman GJ, Rudensky AY, Ahmed R.

J Exp Med. 2014 Aug 25;211(9):1905-18. doi: 10.1084/jem.20132577. Epub 2014 Aug 11.

19.

Cell entry of lymphocytic choriomeningitis virus is restricted in myotubes.

Iwasaki M, Urata S, Cho Y, Ngo N, de la Torre JC.

Virology. 2014 Jun;458-459:22-32. doi: 10.1016/j.virol.2014.04.013. Epub 2014 May 5. Erratum in: Virology. 2014 Jun;458-459:209.

20.

Supplemental Content

Support Center